- Home
- PLBY vs ORMP Comparison
PLBY vs ORMP Comparison
Compare PLBY & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLBY | ORMP |
|---|---|---|
| Founded | 1953 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.4M | 165.3M |
| IPO Year | 2020 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PLBY | ORMP |
|---|---|---|
| Price | $1.35 | $4.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 654.9K | 238.1K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 87.50 | ★ 412.50 |
| EPS | N/A | ★ 0.91 |
| Revenue | ★ $120,928,000.00 | $2,000,000.00 |
| Revenue This Year | $9.17 | N/A |
| Revenue Next Year | $7.10 | N/A |
| P/E Ratio | ★ N/A | $5.49 |
| Revenue Growth | 4.13 | ★ 49.25 |
| 52 Week Low | $1.19 | $1.98 |
| 52 Week High | $2.75 | $5.19 |
Technical Indicators
Market Signals| Indicator | PLBY | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 46.71 | 68.02 |
| Support Level | $1.23 | $3.21 |
| Resistance Level | $1.48 | $5.01 |
| Average True Range (ATR) | 0.08 | 0.24 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 33.85 | 74.09 |
Price Performance
Historical ComparisonAbout PLBY PLBY Group Inc.
Playboy Inc, formerly PLBY Group Inc connects consumers around the world with products, services, and experiences to help them look good, feel good, and have fun. PLBY Group serves consumers in four categories: Style and Apparel, Digital Entertainment and Lifestyle, Sexual Wellness, and Beauty and Grooming. It operates through three segments Direct-to-Consumer, Licensing, and Digital Subscriptions and Content. It generates revenue through the sales of products and content services to consumers.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.